Li Jia-Nan, Li Qiang, Fang Yi-Bin, Huang Qing-Hai, Hong Bo, Zhao Rui, Xu Yi, Liu Jian-Min
Department of Neurosurgery & Stroke Center, Changhai Hospital, Second Military Medical University, Shanghai, China.
Department of Neurosurgery & Stroke Center, Changhai Hospital, Second Military Medical University, Shanghai, China.
World Neurosurg. 2020 Apr;136:e75-e82. doi: 10.1016/j.wneu.2019.10.103. Epub 2019 Nov 22.
Endovascular embolization with transvenous sinus preservation using balloon is at present the preferred modality for dural arteriovenous fistulas involving venous sinuses (sagittal, transverse, and sigmoid) with potential drainage function. The aim of the study was to evaluate the necessity and medium-term efficacy of this technique.
Patients with dural arteriovenous fistulas involving large sinuses who underwent vascular embolization with transvenous balloon protection technique at our center from December 2012 to July 2017 were retrospectively reviewed. The clinical symptoms, postoperative and mid-term follow-up imaging results, perioperative complications, and follow-up clinical outcomes were analyzed.
Eighteen patients (8 women and 10 men) with mean age 49 years were included in this study. Complete (16 of 18) or near-complete (1 of 18) occlusion of original fistula was achieved in 17 patients (94.4%). Recurrence of original fistula (1 of 18) or de novo fistula (3 of 18) occurred in 4 patients (22.2%). The patency rate of balloon-protected sinus was 72.2% (13 of 18) during the follow-up, and the involved sinuses were eventually occluded in 5 patients (27.8%). The frequency of de novo fistulas was higher in patients with sinus occlusion (P < 0.05). Stenosis of the involved sinus was more likely related to balloon-protected sinus occlusion (P < 0.05). After a mean follow-up of 17.6 months, 17 patients (94.4%) achieved remission of the original symptoms.
Transvenous balloon protection technique maintains sinus patency in most cases, and preoperative stenosis increases the probability of sinus occlusion. De novo fistula is related to sinus occlusion during the follow-up.
目前,使用球囊经静脉保留窦的血管内栓塞术是治疗累及具有潜在引流功能的静脉窦(矢状窦、横窦和乙状窦)的硬脑膜动静脉瘘的首选方式。本研究的目的是评估该技术的必要性和中期疗效。
回顾性分析2012年12月至2017年7月在我院中心接受经静脉球囊保护技术血管栓塞治疗的累及大静脉窦的硬脑膜动静脉瘘患者。分析临床症状、术后及中期随访影像学结果、围手术期并发症及随访临床结局。
本研究纳入18例患者(8例女性,10例男性),平均年龄49岁。17例患者(94.4%)实现了原瘘口的完全(18例中的16例)或近乎完全(18例中的1例)闭塞。4例患者(22.2%)出现原瘘口复发(18例中的1例)或新发瘘口(18例中的3例)。随访期间,球囊保护窦的通畅率为72.2%(18例中的13例),5例患者(27.8%)的受累静脉窦最终闭塞。静脉窦闭塞患者新发瘘口的发生率更高(P<0.05)。受累静脉窦狭窄更可能与球囊保护静脉窦闭塞有关(P<0.05)。平均随访17.6个月后,17例患者(94.4%)原症状缓解。
经静脉球囊保护技术在大多数情况下可维持静脉窦通畅,术前狭窄会增加静脉窦闭塞的概率。随访期间新发瘘口与静脉窦闭塞有关。